CNO Financial Group (CNO)

NYSEFinancialsInsurance - LifeSnapshot 2026-10-23

$53.66-3.32%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge CNO Financial Group’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	1.03B
EPS	—	1.325
Annual ending 2026-12-31
Revenue	—	4.07B
EPS	—	4.747
Annual ending 2027-12-31
Revenue	—	4.2B
EPS	—	5.096

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Stable management and execution	The stable management and low risk profile add confidence.	Intact	Significant management turnover or execution failures reported	No major disruptions; 1 routine director retirement Raised 2026 EPS guidance, Q2 earnings beat, and routine director retirement confirm stable management and positive execution. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Operating EPS between $4.25 and $4.45 for fiscal year 2026	CNO Financial Group targets operating EPS between $4.25 and $4.45 for 2026.	Broken	Operating EPS falls below $4.25 or above $4.45 in FY26	Diluted EPS: $1.33 per share FY2026-Q2; GAAP. Published target: >=4.25 USD per share and <=4.45 USD per share. Target period is not explicitly aligned with this observation. Source published Aug 6, 20261.33 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: ec0ada7e-615f-4385-ae8a-8f803c7cff9e. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain profit margins near current levels	Profit margins remain robust, supporting steady earnings.	Intact	Profit margins fall significantly below 25% in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue growth near consensus of -5% in next 12 months	A primary condition in CNO Financial Group's published investment case. The stated target is >=-5% YoY revenue growth.	Improving	Revenue decline worse than -5% YoY over next 12 months	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPSUnavailable

$4.94 → Unavailable · observed estimates

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$4.94	Unavailable	5 / 2
2026-07-25	$4.94	Unavailable	5 / 2
2026-07-26	$4.94	Unavailable	5 / 2
2026-07-27	$4.94	Unavailable	5 / 2
2026-07-28	$4.94	Unavailable	5 / 2
2026-07-29	Unavailable	Unavailable	3 / 1
2026-07-30	$4.94	Unavailable	5 / 2
2026-07-31	Unavailable	Unavailable	3 / 1
2026-08-01	Unavailable	Unavailable	3 / 1
2026-08-02	$4.94	Unavailable	5 / 2
2026-08-03	Unavailable	Unavailable	3 / 1
2026-08-04	Unavailable	Unavailable	3 / 1
2026-08-05	Unavailable	Unavailable	3 / 1
2026-08-06	$4.94	Unavailable	5 / 2
2026-08-07	Unavailable	Unavailable	3 / 1
2026-08-08	$4.95	Unavailable	5 / 2
2026-08-09	$4.95	Unavailable	5 / 2
2026-08-10	Unavailable	Unavailable	3 / 1
2026-08-11	$4.98	Unavailable	5 / 2
2026-08-12	$5.00	Unavailable	5 / 1
2026-08-13	$5.00	Unavailable	5 / 1
2026-08-14	Unavailable	Unavailable	3 / 1
2026-08-15	Unavailable	Unavailable	3 / 1
2026-08-16	Unavailable	Unavailable	3 / 1
2026-08-17	Unavailable	Unavailable	3 / 1
2026-08-18	Unavailable	Unavailable	3 / 1
2026-08-19	Unavailable	Unavailable	3 / 1
2026-08-20	Unavailable	Unavailable	2 / 1
2026-08-21	Unavailable	Unavailable	2 / 1
2026-08-22	Unavailable	Unavailable	2 / 1
2026-08-23	Unavailable	Unavailable	2 / 1
2026-08-24	Unavailable	Unavailable	2 / 1
2026-08-25	Unavailable	Unavailable	2 / 1
2026-08-26	Unavailable	Unavailable	2 / 1
2026-08-27	Unavailable	Unavailable	2 / 1
2026-08-28	Unavailable	Unavailable	2 / 1
2026-08-29	Unavailable	Unavailable	2 / 1
2026-08-30	Unavailable	Unavailable	2 / 1
2026-08-31	Unavailable	Unavailable	2 / 1
2026-09-01	Unavailable	Unavailable	2 / 1
2026-09-02	Unavailable	Unavailable	2 / 1
2026-09-03	Unavailable	Unavailable	2 / 1
2026-09-04	Unavailable	Unavailable	2 / 1
2026-09-05	Unavailable	Unavailable	2 / 1
2026-09-06	Unavailable	Unavailable	2 / 1
2026-09-07	Unavailable	Unavailable	2 / 1
2026-09-08	Unavailable	Unavailable	2 / 1
2026-09-09	Unavailable	Unavailable	2 / 1
2026-09-10	Unavailable	Unavailable	2 / 1
2026-09-11	Unavailable	Unavailable	2 / 1
2026-09-12	Unavailable	Unavailable	2 / 1
2026-09-13	Unavailable	Unavailable	2 / 1
2026-09-14	Unavailable	Unavailable	2 / 1
2026-09-15	Unavailable	Unavailable	2 / 1
2026-09-16	Unavailable	Unavailable	2 / 1
2026-09-17	Unavailable	Unavailable	2 / 1
2026-09-18	Unavailable	Unavailable	2 / 1
2026-09-19	Unavailable	Unavailable	2 / 1
2026-09-20	Unavailable	Unavailable	2 / 1
2026-09-21	Unavailable	Unavailable	2 / 1
2026-09-22	Unavailable	Unavailable	2 / 1
2026-09-23	Unavailable	Unavailable	2 / 1
2026-09-24	Unavailable	Unavailable	2 / 1
2026-09-25	Unavailable	Unavailable	2 / 1
2026-09-26	Unavailable	Unavailable	2 / 1
2026-09-27	Unavailable	Unavailable	2 / 1
2026-09-28	Unavailable	Unavailable	2 / 1
2026-09-29	Unavailable	Unavailable	2 / 1
2026-09-30	Unavailable	Unavailable	2 / 1
2026-10-01	Unavailable	Unavailable	2 / 1
2026-10-02	Unavailable	Unavailable	2 / 1
2026-10-03	Unavailable	Unavailable	2 / 1
2026-10-04	Unavailable	Unavailable	2 / 1
2026-10-05	Unavailable	Unavailable	2 / 1
2026-10-06	Unavailable	Unavailable	2 / 1
2026-10-07	Unavailable	Unavailable	2 / 1
2026-10-08	Unavailable	Unavailable	2 / 1
2026-10-09	Unavailable	Unavailable	2 / 1
2026-10-10	Unavailable	Unavailable	2 / 1
2026-10-11	Unavailable	Unavailable	2 / 1
2026-10-12	Unavailable	Unavailable	2 / 1
2026-10-13	Unavailable	Unavailable	2 / 1
2026-10-14	Unavailable	Unavailable	2 / 1
2026-10-15	Unavailable	Unavailable	2 / 1
2026-10-16	Unavailable	Unavailable	3 / 1
2026-10-17	Unavailable	Unavailable	3 / 1
2026-10-18	Unavailable	Unavailable	3 / 1
2026-10-19	Unavailable	Unavailable	3 / 1
2026-10-20	Unavailable	Unavailable	3 / 1
2026-10-21	Unavailable	Unavailable	3 / 1
2026-10-22	Unavailable	Unavailable	3 / 1
2026-10-23	Unavailable	Unavailable	3 / 1
2026-10-24	Unavailable	Unavailable	3 / 1

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	1	3	1
2026-06-01	1	4	1
2026-07-01	1	5	0
2026-08-01	0	5	0
2026-09-01	0	5	0
2026-10-01	0	5	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 0 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Operating EPS between $4.25 and $4.45 for fiscal year 2026Published status: Broken
Maintain profit margins near current levelsDirect metric needs a verified mapping
Revenue growth near consensus of -5% in next 12 monthsDirect metric needs a verified mapping

Next proof point

Oct 29, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.8%Typical daily move · historical

Downside history

-11.0%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

CNO Financial Group outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

CNO is an insurance business with a growth-oriented, durable-earnings thesis rather than a turnaround story. The thesis is on watch: management is delivering on stated priorities, but recent financial performance is below its industry cohort.

What's priced into CNO Financial Group

CNO is valued at a 1.53 premium versus peers, and the evidence describes that premium as durable. The expectations gap is zero, while fragility is low, suggesting the valuation is treated as justified rather than dependent on unusually high expectations.

What the fundamentals likely do

Near term, operating earnings and insurance sales have been strong: operating EPS rose 45% in 2026-Q2, new annualized premiums grew 7%, and management raised 2026 operating EPS guidance. However, company momentum fell 15.7 points, recent results are below the industry cohort, and earnings surprises have been erratic.

What CNO Financial Group hinges on

Over the multi-year view, the thesis hinges on sustaining earnings growth, sales growth, and disciplined capital management. Near-term risks include a reversal of the recent guidance increase and interest-rate cuts; continued earnings strength among sector peers would support the sector backdrop.